TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A Monash University-led study across 31 Australian general practices found that a 12-month nurse-led program was associated with improved estimated dementia risk profiles among adults aged 45 to 65. The trial measured risk-factor changes, not dementia diagnoses or prevention; follow-up data will examine whether the changes last.
A Monash University-led study found that a 12-month program delivered by general practice nurses improved estimated dementia risk profiles among middle-aged adults with modifiable risk factors. Published in The Lancet Regional Health – Western Pacific, the Australian trial compared a nurse-supported program and app with standard care across 31 general practices; it assessed changes in risk scores, not whether participants developed dementia or avoided cognitive decline.
The study included more than 403 adults aged 45 to 65. Participants in the intervention group received five nurse consultations, a personalized action plan and access to the purpose-built HAPPI MIND app, which supported self-monitoring and goal tracking. The comparison group received standard risk assessment results and educational material.
After 12 months, 56% of intervention participants showed improvement in their dementia risk profile, compared with 44% in the comparison group. The researchers reported a statistically significant improvement in risk scores for the nurse-led program relative to standard care. They said changes in protective lifestyle behaviors, including physical activity, fish intake and body mass index status, accounted for much of the improvement.
The findings concern estimated risk profiles and modifiable factors, rather than clinical outcomes. The researchers did not report that the program reduced dementia diagnoses, demonstrated prevention or changed cognitive function. Those distinctions matter when interpreting an improvement in a risk score.
Primary Care Support for Brain Health
The results point to a possible way for general practices to support people in addressing modifiable midlife risk factors: structured nurse consultations paired with a tool for tracking goals between visits. Rather than relying only on written information, the program offered participants individual support to turn risk assessment results into practical actions.
The approach could be relevant to health services seeking to integrate brain-health discussions into routine care. Senior author Associate Professor Johnson George said the model uses primary care to connect people with strategies they can work on and follow over time. However, the study does not establish that this particular program prevents dementia. Its measured outcome was change in estimated risk over one year, and longer-term results are still needed.
The wider issue has public-health relevance in Australia. The Australian Institute of Health and Welfare estimates that 459,000 Australians are living with dementia in 2026, and projects the number will exceed one million by 2066. The trial offers evidence about an intervention aimed at risk factors, not a solution to that projected increase.
Popular right now
Samsung 42-Inch S90H OLED 4K Smart TV Bundle
Bose QuietComfort Wireless Noise-Cancelling Over-Ear Headphones, Black
Dyson Cyclone V10 Origin Cordless Vacuum
As an affiliate, we earn on qualifying purchases.
A One-Year General Practice Trial
The study builds on interest in addressing dementia-related risk factors before older age. Its authors said the research follows the publication of the World Health Organization’s guidelines on reducing the risk of cognitive decline and dementia, as well as a Monash-led update to Australia’s Clinical Practice Guidelines for Dementia.
In the trial, the intervention combined five consultations with a practice nurse and access to HAPPI MIND. Nurses helped participants identify areas to work on and set targets; the app let them monitor goals between appointments. The comparison group received assessment results and educational material, providing a standard-care benchmark.
That design tests whether added personal support and digital tracking can improve measured risk profiles in an existing primary-care setting. It does not, on its own, establish how well the program would work at scale, whether all practices could deliver it in the same way, or whether the score changes would lead to long-term health benefits.
Long-Term Effects Remain Unmeasured
The trial followed participants for 12 months and measured estimated risk profiles. It did not track long-term dementia diagnoses or establish whether the intervention prevents cognitive decline. The source material also does not provide the size of the average score change, detailed participant characteristics, or enough information to assess how the program performed across different groups.
It remains unclear whether the reported improvements will persist, whether they translate into meaningful differences in later health outcomes, and how the program would perform if adopted more widely. The fact that 44% of the comparison group also improved is another reason to interpret the intervention result in comparison with standard care, rather than as an effect experienced by every participant.
Researchers Plan 36-Month Follow-Up
The research team plans to examine 36-month follow-up data to see whether the early risk-profile improvements last. That analysis may provide more information about the durability of changes, although the source material does not say whether it will assess dementia diagnoses or other clinical outcomes.
For now, the findings support further evaluation of nurse-led, app-supported risk reduction in general practice. Dr Sarwar said wider delivery would depend on further evaluation. The study does not establish that the program is ready for broad rollout or that it can prevent dementia.
Key Questions
What did the Monash study find?
It found a statistically significant improvement in estimated dementia risk scores after a 12-month nurse-led program, compared with standard care. Fifty-six percent of intervention participants showed improvement, versus 44% in the comparison group.
What did participants receive?
Participants in the intervention group had five nurse consultations, a personalized action plan and access to the HAPPI MIND app for tracking goals. The comparison group received standard risk assessment results and educational material.
Did the program prove it prevents dementia?
No. The trial measured changes in estimated risk profiles over 12 months, not long-term dementia diagnoses or prevention of cognitive decline. The researchers say longer follow-up is needed.
What happens next?
The researchers plan to review 36-month follow-up data to assess whether the early improvements last. The source material does not give a publication date for those results.
Source: news-medical.net
